Human Simplex Virus (HSV 2) Archives -
Home Tags Human Simplex Virus (HSV 2)

Tag: Human Simplex Virus (HSV 2)

A revolution in nanotech helps create a new vaccine delivery system that could literally...

The Nanopatch, a revolutionary new needle-free device for delivering vaccines, has won a $15 million capital injection (pun intended), but also was an award winner at World Vaccine Congress. After eight years of research, the Nanopatch looks set to revolutionise vaccination delivery forever.

Queensland biotech startup Vaxxas gets $15 million from venture funds

Vaxxas Pty. Ltd. has won a $15 million investment from venture groups led by OneVentures. Other investors include Brandon Capital Partners, the Medical Research Commercialisation Fund and U.S.-based HealthCare Ventures. Vaxxas is the first Queensland company to be funded under the Bio Capital Fund, which has swelled to nearly $250 million, established last year with the help of Health Care Ventures and Eli Lilly, among others. The investment was negotiated in the main by UniQuest Pty Limited, the University of Queensland’s main commercialisation company.

FREE BUSINESS TOOLS

Three easy wins when using LinkedIn with David Hobson [FREE REPORT]

"If you’re pressed for time, I'm here to help." In this report, David Hobson will show you three quick wins - things you can do to pimp out your LinkedIn profile in 15 minutes or less.

FREE BUSINESS TOOL

How to expand into New Markets with Elsita Meyer-Brandt [CHEAT SHEET]

Most organisations begin with aspirations to start local, then grow global. But, in reality, very few ever take the big leap into new markets. In this Cheat Sheet, Elsita Meyer-Brandt, Head of Market Expansion and International Marketing for Eventbrite, shares five rules to help organisations, just like yours, expand into new markets.

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE